Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Author(s) -
Aart Jan van der Lely,
R. Kent Hutson,
Peter Trainer,
G. M. Besser,
Ariel L. Barkan,
Laurence Katznelson,
Anne Klibanski,
Vivien Herman-Bonert,
Шломо Мелмед,
Mary Lee Vance,
Pamela U. Freda,
Paul M. Stewart,
Keith Friend,
David R. Clemmons,
Gudmundur Johannsson,
Stavros Stavrou,
David M. Cook,
Lawrence S. Phillips,
Christian J. Strasburger,
Suzanne Hackett,
Kenneth Zib,
Robert J. Davis,
John A. Scarlett,
Michael O. Thorner
Publication year - 2001
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/82mk-gm08
Subject(s) - pegvisomant , acromegaly , antagonist , endocrinology , medicine , term (time) , growth hormone , receptor , hormone , pharmacology , physics , quantum mechanics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom